MED

MEDIFAST INC

MED·58470H101·US·Common Stock·Consumer Cyclical - Personal Services-Activist

MED (MEDIFAST INC) is held by 65 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($9.6M), RENAISSANCE TECHNOLOGIES LLC ($7.9M), CHARLES SCHWAB INVESTMENT MANAGEMENT INC ($6.4M). Net institutional sentiment: Mixed.

65
Holders
Avg rating(17 Elite)
$70.3M
Total Value
53% (75)
Fund Consensus
37 buying - 33 selling
MEDSmart Money Verdict
View all
Held by 65 funds
17 elite
Who's Trading
ActivistCSCitadel Securities GP LLC6.5%May 15, 2026
ActivistRenaissance Technologies LLCRenaissance Technologies LLC7.0%May 14, 2026
InsiderSSSCHLACKMAN SCOTTBuy $31KMay 11, 2026
InsiderSSSCHLACKMAN SCOTTBuy $32KMay 8, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderCRChard Daniel RBuy $179KMar 20, 2026
ActivistSTSteamboat Capital Partners, LLC6.0%Mar 20, 2026
ActivistGEG1 Execution Services, LLC1.4%Feb 13, 2026
InsiderCRChard Daniel RBuy $5KJun 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
944,453(+3.2%)$9.6M0.0%-38.25%
29
Decreased
773,710(-0.9%)$7.9M0.0%-86.18%
0
Decreased
631,539(-18.7%)$6.4M0.0%-56.65%
0
New
444,467$4.5M0.0%+2.49%
37
Increased
361,762(+10.9%)$3.7M0.0%-80.30%
30
Increased
338,158(+320.9%)$3.4M0.0%-16.53%
43
Decreased
325,312(-2.9%)$3.3M0.0%-39.24%
0
Increased
253,315(+2.4%)$2.6M0.0%-90.38%
27
Decreased
236,212(-0.1%)$2.4M0.0%-83.82%
0
Increased
224,280(+3.0%)$2.3M0.0%-79.02%
27
Increased
222,638(+0.4%)$2.3M0.0%-83.13%
26
New
202,829$2.1M0.0%+2.49%
36
Decreased
183,035(-44.6%)$1.9M0.0%-22.54%
0
Increased
180,081(+41.8%)$1.8M0.0%-21.47%
34
Decreased
160,564(-26.7%)$1.6M0.0%-62.10%
0
Decreased
153,171(-15.3%)$1.6M0.0%-36.07%
0
Increased
145,575(+10.7%)$1.5M0.0%-63.99%
28
New
126,407$1.3M0.0%+2.49%
35
Increased
92,595(+5.6%)$943,5440.0%-88.82%
26
Decreased
88,777(-8.9%)$904,6370.0%-33.77%
0

Showing 1-20 of 75

1 / 4

Other Consumer Cyclical stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used